The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Open Access
- 3 March 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 773
Abstract
Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes, with a grave prognosis and few effective treatment options. Organoids represent revolutionary three-dimensional cell culture models, derived from stem or differentiated cells and preserving the capacity to differentiate into the cell types of their tissue of origin. The current review aims at studying the potential of patient-derived TNBC organoids for drug sensitivity testing as well as highlighting the advantages of the organoid technology in terms of drug screening. In order to identify relevant studies, a literature review was conducted using the MEDLINE and LIVIVO databases. The search terms “organoid” and “triple-negative breast cancer” were employed, and we were able to identify 25 studies published between 2018 and 2022. The current manuscript represents the first comprehensive review of the literature focusing on the use of patient-derived organoids for drug sensitivity testing in TNBC. Patient-derived organoids are excellent in vitro study models capable of promoting personalized TNBC therapy by reflecting the treatment responses of the corresponding patients and exhibiting high predictive value in the context of patient survival evaluation.Keywords
This publication has 57 references indexed in Scilit:
- Modeling Development and Disease with OrganoidsCell, 2016
- Modeling mouse and human development using organoid culturesDevelopment, 2015
- Organogenesis in a dish: Modeling development and disease using organoid technologiesScience, 2014
- Synthetic 3D multicellular systems for drug developmentCurrent Opinion in Biotechnology, 2012
- Triple-negative breast cancer: epidemiological considerations and recommendationsAnnals of Oncology, 2012
- Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's EpitheliumGastroenterology, 2011
- Exploring Molecular Pathways of Triple-Negative Breast CancerGenes & Cancer, 2011
- Triple-Negative Breast CancerAmerican Journal of Clinical Oncology, 2010
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheNature, 2009
- A murine tumor producing a matrix of basement membrane.Journal of Experimental Medicine, 1977